
|Articles|January 1, 2003
Botox battles heat up
Author(s)Timothy N. Troy
Palm Beach, Fla. - Dermatologists apparently have had enough hype, spam, and promotion of new retail creams claiming to be "better" than mainstay anti-aging products. The upshot is a first-ever clinical comparison of such topicals to botulinum toxin A, a wrinkle fighter turned household word by Allergan's Botox Cosmetic.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
5


















